243 related articles for article (PubMed ID: 30190333)
21. Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model.
Qiao H; Wang TY; Yu ZF; Han XG; Liu XQ; Wang YG; Fan QM; Qin A; Tang TT
Cell Death Dis; 2016 Feb; 7(2):e2094. PubMed ID: 26866274
[TBL] [Abstract][Full Text] [Related]
22. IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.
Fang M; Li Y; Huang K; Qi S; Zhang J; Zgodzinski W; Majewski M; Wallner G; Gozdz S; Macek P; Kowalik A; Pasiarski M; Grywalska E; Vatan L; Nagarsheth N; Li W; Zhao L; Kryczek I; Wang G; Wang Z; Zou W; Wang L
Cancer Res; 2017 May; 77(10):2735-2745. PubMed ID: 28249897
[TBL] [Abstract][Full Text] [Related]
23. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
25. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI
Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells.
Gonzalez-Villasana V; Gutiérrez-Puente Y; Tari AM
Oncol Rep; 2013 Sep; 30(3):1506-10. PubMed ID: 23783392
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of radiosensitivity by inhibition of c-Jun N-terminal kinase activity in a Lewis lung carcinoma‑bearing subcutaneous tumor mouse model.
Li CH; Lim SH; Ryu HH; Moon KS; Jung TY; Jung S
Oncol Rep; 2016 Dec; 36(6):3397-3404. PubMed ID: 27779695
[TBL] [Abstract][Full Text] [Related]
28. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
29. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
[TBL] [Abstract][Full Text] [Related]
30. Involvement of c-Jun N-Terminal Kinase in TNF-α-Driven Remodeling.
Eurlings IM; Reynaert NL; van de Wetering C; Aesif SW; Mercken EM; de Cabo R; van der Velden JL; Janssen-Heininger YM; Wouters EF; Dentener MA
Am J Respir Cell Mol Biol; 2017 Mar; 56(3):393-401. PubMed ID: 27875656
[TBL] [Abstract][Full Text] [Related]
31. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway.
Zou S; Yang J; Guo J; Su Y; He C; Wu J; Yu L; Ding WQ; Zhou J
Cancer Lett; 2018 Mar; 417():65-74. PubMed ID: 29306013
[TBL] [Abstract][Full Text] [Related]
32. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
Sun ZL; Dong JL; Wu J
Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
[TBL] [Abstract][Full Text] [Related]
33. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.
Schiff R; Reddy P; Ahotupa M; Coronado-Heinsohn E; Grim M; Hilsenbeck SG; Lawrence R; Deneke S; Herrera R; Chamness GC; Fuqua SA; Brown PH; Osborne CK
J Natl Cancer Inst; 2000 Dec; 92(23):1926-34. PubMed ID: 11106684
[TBL] [Abstract][Full Text] [Related]
35. Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.
Sun Q; Lesperance J; Wettersten H; Luterstein E; DeRose YS; Welm A; Cheresh DA; Desgrosellier JS
J Clin Invest; 2018 Jan; 128(1):531-544. PubMed ID: 29227280
[TBL] [Abstract][Full Text] [Related]
36. Black Rice Anthocyanins Suppress Metastasis of Breast Cancer Cells by Targeting RAS/RAF/MAPK Pathway.
Chen XY; Zhou J; Luo LP; Han B; Li F; Chen JY; Zhu YF; Chen W; Yu XP
Biomed Res Int; 2015; 2015():414250. PubMed ID: 26649302
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
38. The extracellular matrix in breast cancer.
Insua-Rodríguez J; Oskarsson T
Adv Drug Deliv Rev; 2016 Feb; 97():41-55. PubMed ID: 26743193
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells.
Pinkas J; Martin SS; Leder P
Mol Cancer Res; 2004 Oct; 2(10):551-6. PubMed ID: 15498929
[TBL] [Abstract][Full Text] [Related]
40. miR-200-containing extracellular vesicles promote breast cancer cell metastasis.
Le MT; Hamar P; Guo C; Basar E; Perdigão-Henriques R; Balaj L; Lieberman J
J Clin Invest; 2014 Dec; 124(12):5109-28. PubMed ID: 25401471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
